Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict

Robert A Bailey, Michael Pfeifer, Alicia C Shillington, Qing Harshaw, Martha M Funnell, Jeffrey VanWingen, Nanada Col, Robert A Bailey, Michael Pfeifer, Alicia C Shillington, Qing Harshaw, Martha M Funnell, Jeffrey VanWingen, Nanada Col

Abstract

Background: Patients with type 2 diabetes (T2DM) often have poor glycemic control on first-line pharmacologic therapy and require treatment intensification. Intensification decisions can be difficult because of many available options and their many benefits and risks. The American Diabetes Association recommends patient-centered, evidence-based tools supporting shared decision-making between patients and clinicians. We developed a patient decision aid (PDA) targeting decisions about treatment intensification for T2DM. Our objective was to determine the effectiveness of this PDA for patients with T2DM on metformin who require treatment intensification.

Methods: This study was a pragmatic randomized controlled trial conducted in 27 US primary care and endocrinology clinics. Subjects were English-speaking adults with T2DM receiving metformin with persistent hyperglycemia who were recommended to consider medication intensification. Subjects were randomized to receive either the PDA or usual care (UC). Main outcome measures were change in knowledge, decisional self-efficacy, and decisional conflict.

Results: Of 225 subjects enrolled, 114 were randomized to the PDA and 111 to UC. Mean [SD] age was 52 [1] years, time since T2DM diagnosis was 6 [+/-6] years, 45.3% were male, and most (55.5%) were non-Caucasian. Compared to UC, PDA users had significantly larger knowledge gains (35.0% [22.3] vs 9.9% [22.2]; P < 0.0001) and larger improvements in self-efficacy (3.7 [16.7] vs-3.9 [19.2]; P < 0.0001) and decisional conflict (-22.2 [20.6] vs-7.5 [16.6]; P < 0.0001).

Conclusions: The PDA resulted in substantial and significant improvements in knowledge, decisional conflict and decisional self-efficacy. Decisional conflict scores after PDA use were within the range that correlates with effective decision-making. This PDA has the potential to facilitate shared-decision-making for patients with T2DM.

Trial registration: NCT02110979.

Figures

Fig. 1
Fig. 1
Type 2 Diabetes Medications Comparison Chart*. PDA “Fact Sheet”
Fig. 2
Fig. 2
Subject Disposition
Fig. 3
Fig. 3
Subject Values Scores At Baseline for Outcomes Related to Treatment

References

    1. Sarkar U, Fisher L, Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? Diabetes Care. 2006;29(4):823–829. doi: 10.2337/diacare.29.04.06.dc05-1615.
    1. Tunrer R, on behalf of the UKPDS Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1999;354:602.
    1. Shamoon H, Duffy H, Fleischer N, Engel S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N Engl J Med. 1993;329(14):977–986. doi: 10.1056/NEJM199309303291401.
    1. Garber A, Abrahamson M, Barzilay J, Blonde L, Bloomgarden Z, Bush M, et al. AACE/ACE Comprehensive diabetes management algorithm 2015. Endo Pract. 2015;21:438–447. doi: 10.4158/EP15693.CS.
    1. Williams M, Baker D, Parker R, Nurss J. Relationship of functional health literacy to patients’ knowledge of their chronic disease - A study of patients with hypertension and diabetes. Arch of Int Med. 1998;158:166–172. doi: 10.1001/archinte.158.2.166.
    1. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93:1–9. doi: 10.1016/j.diabres.2011.02.002.
    1. Fisher L, Hessler D, Masharani U. Impact of baseline patient characteristics on interventions to reduce diabetes distress: the role of personal conscientiousness and diabetes self-efficacy. Diabet Med. 2014;31(6):739–746. doi: 10.1111/dme.12403.
    1. Martin-Harris B, Gebregziabher M, Walker Rebekah J, Egede LE, et al. Understanding the influence of psychological and socioeconomic factors diabetes self-care using structured equation modeling. Patient Educ Couns. 2015;98(1):34–40. doi: 10.1016/j.pec.2014.10.002.
    1. Schwarzer R. Modeling health behavior change: how to predict and modify the adoption and maintenance of health behaviors. J Appl Psychol. 2008;57(1):1–29. doi: 10.1111/j.1464-0597.2007.00325.x.
    1. O’Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25–30. doi: 10.1177/0272989X9501500105.
    1. O’Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H, et al. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ. 1999;319(7212):731–734. doi: 10.1136/bmj.319.7212.731.
    1. King DK, Glasgow RE, Toobert DJ, Strycker LA, Estabrooks PA, Osuna D, et al. Self-efficacy problem solving, and social-environmental support are associated with diabetes self-management behaviors. Diabetes Care. 2010;33(4):751–753. doi: 10.2337/dc09-1746.
    1. Gonzalez JS, Shreck P, Psaros C, Safrin SA. Distress and type 2 diabetes-treatment adherence: a mediating role for perceived control. Health Psychol. 2015;34(5):505–513. doi: 10.1037/hea0000131.
    1. Adam J, Folds L. Depression, self-efficacy, and adherence in patients with type 2 diabetes. J Nur Pract. 2014;10(9):42–48.
    1. Berikai P, Meyer PM, Kazlauskaite R, Savoy B, Kozik K, Fogelfeld L. Gain in patients' knowledge of diabetes management targets is associated with better glycemic control. Diabetes Care. 2007;20(6):1587–1589. doi: 10.2337/dc06-2026.
    1. Sousa VD, Zauszniewski JA, Musil CM, Price Lea PJ, Davis SA. Relationships among selfcare agency, self-efficacy, self-care, and glycemic control. Res Theory Nurs Pract. 2005;19(3):217–30. doi: 10.1891/rtnp.2005.19.3.217.
    1. McPherson ML. Association between diabetes patients’ knowledge about medications and their blood glucose control. Res SocialAdmin Pharm. 2008;4(1):37–45.
    1. American Diabetes Association Standards of medical care in diabetes. Diabtes Care. 2014;37(Suppl 1):S14–80. doi: 10.2337/dc14-S014.
    1. Moreno G, Mangione CM, Kimbro L, Vaisberg E. Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update. J Am Geriatr Soc. 2013;61(11):2020–2026. doi: 10.1111/jgs.12513.
    1. Woolf SH, Chan ECY, Harris R, Sheridan SL, Braddock CH, 3rd, Kaplan RM, et al. Promoting informed choice: transforming health care to dispense knowledge for decision making. Ann Intern Med. 2005;143(4):293–300. doi: 10.7326/0003-4819-143-4-200508160-00010.
    1. Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient-centered care. NEJM. 2012;366(9):780–781. doi: 10.1056/NEJMp1109283.
    1. Braddock CH, 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282(24):2313–2320. doi: 10.1001/jama.282.24.2313.
    1. Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA. 2015;175(3):356–362.
    1. Tseng CL, Soroka O, Maney M, Aron DC, Pogach LM. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA Intern Med. 2014;174:259–68. doi: 10.1001/jamainternmed.2013.12963.
    1. Institute of Medicine. Crossing the quality chasm. . Accessed October 7, 2015.
    1. Legare F, Ratte S, Gravel K. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’ perceptions. Pat Ed and Couns. 2008;73(3):526–535. doi: 10.1016/j.pec.2008.07.018.
    1. Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. 2014;1:1–332.
    1. Nannenga MR, Montori VM, Weymiller AJ, Smith SA, Christianson TJ, Bryant SC, et al. A treatment decision aid may increase patient trust in the diabetes specialist: the Statin choice randomized trial. Health Expect. 2009;12:38–44. doi: 10.1111/j.1369-7625.2008.00521.x.
    1. Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007;167:1076–82. doi: 10.1001/archinte.167.10.1076.
    1. Jones LA, Weymiller AJ, Shah N, Bryant SC, Christianson TJ, Guyatt GH, et al. Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results. Med Decis Making. 2009;29:468–74. doi: 10.1177/0272989X09333120.
    1. Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T. The Statin Choice decision aid in primary care: a randomized trial. Patient Educ Couns. 2010;80:138–40. doi: 10.1016/j.pec.2009.10.008.
    1. Corser W, Holmes-Rovner M, Lein C, Gossain V. A shared decision-making primary care intervention for type 2 diabetes. Diabetes Educ. 2007;33(4):700–8. doi: 10.1177/0145721707304086.
    1. Denig P, Schuling J, Haaijer-Ruskamp F, Voorham J. Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ. 2014;349:g5651. doi: 10.1136/bmj.g5651.
    1. Edwards A, Thomas R, Williams R, Ellner AL, Brown P, Elwin G. Presenting risk information to people with diabetes: evaluating effects and preferences for different formats by a web-based randomised controlled trial. Pat Edu Couns. 2006;63:336–49. doi: 10.1016/j.pec.2005.12.016.
    1. Mathers N, Ng CJ, Campbell MJ, Colwell B, Brown I, Bradley A. Clinical effectiveness of a patient decision aid to improve decision quality and glycaemic control in people with diabetes making treatment choices: a cluster randomised controlled trial (PANDAs) in general practice. BMJ OPEN. 2012;2(6):e001469. doi: 10.1136/bmjopen-2012-001469.
    1. Branda ME, LeBlanc A, Shah ND, Tiedje K, Ruud K, Van Houten H, et al. Shared decision making for patients with type 2 diabetes: a randomized trial in primary care. BMC Heal Serv Res. 2013;13:30113. doi: 10.1186/1472-6963-13-301.
    1. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment: results of a randomized controlled trial. Diabetes Care. 1995;18(7):943–949. doi: 10.2337/diacare.18.7.943.
    1. Detry MA, Lewis RJ. The intention-to-treat principle: how to assess the true effect of choosing a medical treatment. JAMA. 2014;312(1):85–86. doi: 10.1001/jama.2014.7523.
    1. Montori VM, Guyatt GH. The intention-to-treat principle. Can Med Assoc J. 2001;165(10):1339–1341.
    1. Shillington AC, Col N, Bailey RA, Jewell MA. Development of a patient decision aid for type 2 diabetes mellitus for patients not achieving glycemic control on metformin alone. Patient Pref Adherence. 2015;9:609–617. doi: 10.2147/PPA.S82555.
    1. Fagerlin A, Pignone M, Abhyankar P, Col N, Feldman-Stewart D, Gavaruzzi T, et al. Clarifying values: an updated review. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S8. doi: 10.1186/1472-6947-13-S2-S8.
    1. International Patient Decision Aids Standards Collaboration. Accessed Oct 1, 2015.
    1. O’Connor A. User manual – stage of decision making. . Accessed Oct 1, 2015
    1. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res. 1997;29(3):21–43.
    1. O’Connor A, Bunn H. Validation of client decision-making instruments in the context of psychiatry. Can J Nurs Res. 1996;28(3):13–27.
    1. O’Connor A. User manual – decisional conflict scale. . Accessed Oct 1, 2015.
    1. . Accessed Oct 1, 2015
    1. Horton NJ. Multiple Imputation in practice. The Am Stat. 2001;55(3):244–254. doi: 10.1198/000313001317098266.
    1. Paget L, Salzberg C, Scholle SH. Building a strategy to leverage health information technology to support patient and family engagement. . Accessed October 10, 2015.
    1. on behalf of he DAWN2 Study Group. Nicolucci A, Burns KK, Holt RIG, Comaschi M, Hermanns N, et al. Diabetes attitudes, wishes and needs second study (DAWN2™): Cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013;30:767–777. doi: 10.1111/dme.12245.
    1. Holt RI, Nicolucci A, Kovacs Burns K, Escalante M, Forbes A, Hermanns N, et al. DAWN2 Study Group. Diabetes attitudes, wishes and needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care--healthcare professional perspective. Diabet Med. 2013;30:789–798. doi: 10.1111/dme.12242.
    1. Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Fischl AH, et al. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators and the Academy of Nutrition and Dietetics. Diabetes Care. 2015;38:1372–1382. doi: 10.2337/dc15-0730.
    1. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies JF. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36:3411–3417. doi: 10.2337/dc13-0331.
    1. Ratanawongsa N, Crosson JC, Schillinger D, Karter AJ, Saha CK, Marrero DG. Getting under the skin of clinical inertia in insulin initiation: the translating research into action for diabetes (TRIAD) insulin starts project. Diabetes Educ. 2012;38:94–100. doi: 10.1177/0145721711432649.
    1. Charles C, Gafni A, Whelan T, O’brien M. Treatment decision aids: conceptual issues and future directions. Health Exp. 2005;8(2):114–125. doi: 10.1111/j.1369-7625.2005.00325.x.
    1. O’Connor A, Wells G, Tugwell P, Laupacis A, Elmslie T, Drake E. The effect of an explicit values clarification exercise in a women’s decision aid regarding postmenopausal hormone therapy. Health Exp. 1999;2:21–32. doi: 10.1046/j.1369-6513.1999.00027.x.
    1. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psy Rev. 1977;84(2):191–215. doi: 10.1037/0033-295X.84.2.191.
    1. Bandura A. Negative self-efficacy and goal effects revisited. J of Appl Psychol. 2003;88(1):87–99. doi: 10.1037/0021-9010.88.1.87.
    1. Atterburn DE, Westbrook EO, Bogart TA, Sepucha KR. Randomized trial of a video-based patient decision aid for bariatric surgery. Obesity. 2011;19:1669–1675. doi: 10.1038/oby.2011.65.
    1. Legare F, Labrecque M, LeBlanc A, Njoya M, Laurier C, Côté L, et al. Training family physicians in shared decision making for the use of antibiotics for acute respiratory infections: a pilot clustered randomized controlled trial. Health Exp. 2010;14(Suppl. 1):96–110.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe